2346
We report an 82-year-old man who developed ventricular tachycardia and Torsades de Pointes (TdP) after oral administration of garenoxacin, a novel quinolone antibiotic agent that differs from the third-generation quinolones, for pneumonia.
 an 82-year-old man: Subject; 82-year-old: Subject.Age; man: Subject.Gender; ventricular tachycardia and Torsades de Pointes (TdP): Effect; oral administration of garenoxacin: Treatment; pneumonia: Treatment.Disorder; oral: Treatment.Route; garenoxacin: Treatment.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 an 82-year-old man: Subject; 82-year-old: Subject.Age; man: Subject.Gender; ventricular tachycardia and Torsades de Pointes (TdP): Effect; oral administration of garenoxacin: Treatment; pneumonia: Treatment.Disorder; oral: Treatment.Route; garenoxacin: Treatment.Drug